Literature DB >> 3489648

Resistance to beta-lactams in Enterobacteriaceae: distribution of phenotypes related to beta-lactamase production.

D Sirot, J Sirot, P Saulnier, B Joly, M Chanal, M Cluzel, R Cluzel.   

Abstract

Phenotypes of susceptibility to amoxycillin (Amo), ticarcillin (Tic), cephalothin (Ctn) were determined in 1366 isolates of Enterobacteriaceae by disk method and beta-lactamases were identified in 243 strains belonging to different phenotypes of amoxycillin-resistant strains. AmoR TicR CtnS strains (25%) were penicillinase producers and all of them were susceptible to the combination amoxycillin/clavulanic acid (Amo/CA) and ticarcillin/clavulanic acid (Tic/CA). Amo1/R TicS CtnR strains (12%) were cephalosporinase producers and resistance to Amo/CA was observed, except for Proteus vulgaris. AmoR TicR CtnR strains (18%) often produced two beta-lactamases (penicillinase and cephalosporinase) and they were resistant to Amo/CA; in this group, susceptibility to Tic/CA depends on the nature and the amount of the beta-lactamase produced, except for Serratia marcescens for which antibiotic resistance is probably due to other mechanisms. Tic/CA resistance was mainly found in Serratia marcescens (41%) and Enterobacter cloacae (36%).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489648     DOI: 10.1177/030006058601400405

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  2 in total

1.  Patterns and mechanisms of beta-lactam resistance among isolates of Escherichia coli from hospitals in the United States.

Authors:  R Cooksey; J Swenson; N Clark; E Gay; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

2.  Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins.

Authors:  A Petit; D L Sirot; C M Chanal; J L Sirot; R Labia; G Gerbaud; R A Cluzel
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.